TY - JOUR
T1 - Prevalence and epidemiological characteristics of COVID-19 after one year of pandemic in Jakarta and neighbouring areas, Indonesia
T2 - A single center study
AU - on behalf of the Wascove team
AU - Setiadi, Wuryantari
AU - Rozi, Ismail Ekoprayitno
AU - Safari, Dodi
AU - Daningrat, Wa Ode Dwi
AU - Johar, Edison
AU - Yohan, Benediktus
AU - Yudhaputri, Frilasita Aisyah
AU - Lestari, Karina Dian
AU - Oktavianthi, Sukma
AU - Myint, Khin Saw Aye
AU - Malik, Safarina G.
AU - Soebandrio, Amin
N1 - Funding Information:
This work was supported by The Ministry of Research and Technology/National Research and Innovation Agency, Republic of Indonesia. The PCR reagents to test outbreak specimens were provided by U.S. Centers for Disease Control and Prevention (US CDC), Indonesian National Board for Disaster Management (Badan Nasional Penanggulangan Bencana; BNPB), Embassy of New Zealand in Indonesia, and Indonesian States Intelligence Agency (Badan Intelijen Negara Republik Indonesia; BIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank multiple health facilities in different regions of Indonesia for submitting respiratory specimens. We also thank the WASCOVE (Waspada COVID-19 Lembaga Biologi Molekuler Eijkman) team, composed by: Lead author: Wuryantari Setiadi tari@eijkman.go.id. Eijkman Institute for Molecular Biology, Jakarta: AA Raka Pratama, Agatha Mia Puspitasari, Ageng Wiyatno, Aghnianditya Kresno Dewantari, Ari Satyagraha, Arkasha Sadewa, Bertha Letizia Utami, Billy Witanto, Chairin Nisa Ma’roef, Chelzie Crenna Darusallam, Chrysantine Paramayuda, Clarissa Asha Febinia, Decy Subekti, Dendi Hadi Permana, Dhita Prabasari Wibowo, Eva Maria Manullang, Evira Cahya Putri, Faiza Az Zahra, Farahana Kresno Dewayanti, Fauzyah Fadlan, Firman Prathama Idris, Gladis R. Hutahaen, Hanifah Fajri Maharani Putri, Hannie Dewi Hadiani Kartapradja, Herawati Sudoyo, Hidayat Trimarsanto, I Made Artika, Indah Delima, Iskandar Alisyahbana Adnan, Jessica Rodearni Saragih, Kartika Saraswati, Korrie Salsabila, Leily Trianty, Lenny Lia Ekawati, Leonard, Leppa Shahrani, Lidwina Priliani, Lydia Visita Pangalo, Marsha S. Santoso, Miftahuddin Majid Khoeri, Muhammad Rezki Razak, Novi Dwi Susilowati, Nunung Nuraini, Rahmadania Marita Joesoef", Rifqi Risandi, Ristya Amalia, Saraswati Soebianto, Sinta Hamidatus Saidah, Tina Kusumaningrum, Ungke Antonjaya, Willy Agustine, Winahyu Handayani, Windy Joanmawanti, Wisiva Tofriska Paraimaswari, Wisnu Tafroji, Yayah Winarti, Yora Permata Dewi, Yulia Widyasanty
Publisher Copyright:
Copyright: © 2022 Setiadi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2022/5
Y1 - 2022/5
N2 - We determined the prevalence and epidemiological characteristics of COVID-19 in Jakarta and neighboring areas, Indonesia from March 2020 to February 2021, based on nasopharyngeal/oropharyngeal (NP/OP) swab specimens that were tested at the Eijkman Institute for Molecular Biology, Jakarta. NP/OP swab specimens were collected from COVID-19 suspects or individuals in contact tracing programs from primary healthcare centers (PHC) and hospitals. The specimens were screened for the SARS-CoV-2 by qRT-PCR. Demography data and clinical symptoms were collected using national standardized laboratory form. Of 64,364 specimens, 10,130 (15.7%) were confirmed positive for SARS-CoV-2, with the peak prevalence of infection in March 2020 (26.3%) follow by in January 2021 (23.9%) and February 2021 (21.8%). We found that the positivity rate of the specimens from Jakarta, West Java, and Banten was 16.3%, 13.3%, and 16.8%, respectively. Positivity rate was higher in specimens from hospitals (16.9%) than PHC (9.4%). Of the positive specimens, 29.6% were from individuals aged >60 years old, followed by individuals aged 41–60 years old (24.2%). Among symptomatic cases of SARS-CoV-2, the most common symptoms were cough, fever, and a combination of both cough & fever. In conclusion, this study illustrates the prevalence and epidemiological characteristics from one COVID-19 diagnostic center in Jakarta and neighbouring areas in Indonesia.
AB - We determined the prevalence and epidemiological characteristics of COVID-19 in Jakarta and neighboring areas, Indonesia from March 2020 to February 2021, based on nasopharyngeal/oropharyngeal (NP/OP) swab specimens that were tested at the Eijkman Institute for Molecular Biology, Jakarta. NP/OP swab specimens were collected from COVID-19 suspects or individuals in contact tracing programs from primary healthcare centers (PHC) and hospitals. The specimens were screened for the SARS-CoV-2 by qRT-PCR. Demography data and clinical symptoms were collected using national standardized laboratory form. Of 64,364 specimens, 10,130 (15.7%) were confirmed positive for SARS-CoV-2, with the peak prevalence of infection in March 2020 (26.3%) follow by in January 2021 (23.9%) and February 2021 (21.8%). We found that the positivity rate of the specimens from Jakarta, West Java, and Banten was 16.3%, 13.3%, and 16.8%, respectively. Positivity rate was higher in specimens from hospitals (16.9%) than PHC (9.4%). Of the positive specimens, 29.6% were from individuals aged >60 years old, followed by individuals aged 41–60 years old (24.2%). Among symptomatic cases of SARS-CoV-2, the most common symptoms were cough, fever, and a combination of both cough & fever. In conclusion, this study illustrates the prevalence and epidemiological characteristics from one COVID-19 diagnostic center in Jakarta and neighbouring areas in Indonesia.
UR - http://www.scopus.com/inward/record.url?scp=85129915641&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0268241
DO - 10.1371/journal.pone.0268241
M3 - Article
C2 - 35550635
AN - SCOPUS:85129915641
SN - 1932-6203
VL - 17
JO - PLoS ONE
JF - PLoS ONE
IS - 5 May
M1 - e0268241
ER -